Development of an immobilized P-glycoprotein stationary phase for on-line liquid chromatographic determination of drug-binding affinities

Journal of Chromatography B: Biomedical Sciences and Applications

Volumn 739, Issue 1, 2000, Pages 33-37

  Zhang, Yanxiao ^a   Leonessa, Fabio ^b   Clarke, Robert ^b   Wainer, Irving W ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Cyclosporin A; Drug binding affinities; P Glycoprotein; Stationary phases, LC; Verapamil

Indexed keywords

CYCLOSPORIN A; GLYCOPROTEIN P; VERAPAMIL; VINBLASTINE;

ARTIFICIAL MEMBRANE; BINDING AFFINITY; CONFERENCE PAPER; DRUG BINDING; LIQUID CHROMATOGRAPHY; ONLINE SYSTEM; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALCIUM CHANNEL BLOCKERS; CHROMATOGRAPHY, AFFINITY; MEMBRANES, ARTIFICIAL; P-GLYCOPROTEIN; VERAPAMIL; VINBLASTINE;

EID: 0033970167     PISSN: 13872273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(99)00384-9     Document Type: Conference Paper

References (25)

1. Higgins C.F. Annu. Rev. Cell Biol. 8:1992;67.
2. Ames G.F.-L., Mimura C., Shyamala V. FEMS Microbiol. Rev. 75:1990;429.
3. Gottesman M.M., Pastan I. Annu. Rev. Biochem. 62:1993;385.
4. A Endicott J., Ling V. Annu. Rev. Biochem. 58:1989;137.
5. Pastan I., Gottesman M.M. N. Engl. J. Med. 316:1987;1388.
6. Cairo M.S., Siegal S., Anas N., Sender I. Cancer Res. 49:1989;1063.
7. Sharom F.J., Yu X., K Chu J.W., Doige C.A. Biochem. J. 308:1994;381.
8. Callaghan R., Berridge G., Ferry D.R., Higgins C.F. Biochem. Biophys. Acta. 1328:1997;109.
9. Ambudkar S.V. J. Bioenerg. Biomembr. 27:1995;23.
10. Sharom F.J., Yu X., Doige C.A. J. Biol. Chem. 268:1993;24197.
11. Shapiro A.B., Ling V. J. Biol. Chem. 269:1994;3745.
12. Eytan G.D., Regev R., Assaraf Y.G. J. Biol. Chem. 271:1996;3172.
13. Cornwell M.M., Gottesman M.M., Pastan I. J. Biol. Chem. 261:1986;7921.
14. Schlemmer S.R., Sirotnak F.M. J. Biol. Chem. 296:1994;31059.
15. Ferry D.R., Russell M.A., Cullen M.H. Biochem. Biophys. Res. Commun. 188:1992;440.
16. Malkhandi J., Ferry D.R., Boer R., Gekeler V., Ise W., Kerr D.J. Eur. J. Pharmacol. 288:1994;105.
17. Ferry D.R., Malkhandi P.J., Russell M.A., Kerr D.J. Biochem. Pharamcol. 49:1995;1851.
18. Zhang Y., Xiao Y., Kellar K.J., Wainer I.W. Anal. Biochem. 264:1998;22.
19. Wainer I.W., Zhang Y., Xiao Y., Kellar K.J. J. Chromatogr. B. 724:1999;65.
20. Pidgeon C., Marcus C., Alvarez F. Baldwin T.O., Kelly J.W. Applications of Enzyme Biotechnology. 1992;201-237 Plenum Press, New York.
21. Wallstén M., Yang Q., Lundahl P. Biochim. Biophys. Acta. 982:1989;47.
22. Yang Q., Lundahl P. Anal. Biochem. 218:1994;210.
23. Leonessa F., Green D., Licht T., Wright A., Wingate-Legette K., Lippman J., Gottesman M.M., Clarke R. Br. J. Cancer. 73:1993;154.
24. Klotz I.M. Trends Pharmacol. Sci. 4:1983;253.
25. Haneskog L., Lindqvist A., Lundahl P. J. Mol. Recogn. 11:1998;58.